Kamada/$KMDA
1D1W1MYTD1Y5YMAX
About Kamada
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
- Ticker
- $KMDA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 462
- Headquarters
- Rehovot, Israel
- Website
- www.kamada.com
Kamada Metrics
BasicAdvanced
$490M
22.65
$0.38
0.13
$0.25
2.90%
Price and volume
Market cap
$490M
Beta
0.13
52-week high
$9.35
52-week low
$6.50
Average daily volume
110K
Dividend rate
$0.25
Financial strength
Current ratio
4.06
Quick ratio
2.293
Long term debt to equity
3.53
Total debt to equity
4.378
Dividend payout ratio (TTM)
64.81%
Interest coverage (TTM)
26.79%
Profitability
EBITDA (TTM)
41.494
Gross margin (TTM)
40.82%
Net profit margin (TTM)
11.60%
Operating margin (TTM)
14.51%
Effective tax rate (TTM)
16.60%
Revenue per employee (TTM)
$420,000
Management effectiveness
Return on assets (TTM)
4.63%
Return on equity (TTM)
8.40%
Valuation
Price to earnings (TTM)
22.655
Price to revenue (TTM)
2.628
Price to book
5.44
Price to tangible book (TTM)
10.09
Price to free cash flow (TTM)
19.157
Free cash flow yield (TTM)
5.22%
Free cash flow per share (TTM)
0.45
Dividend yield (TTM)
2.90%
Forward dividend yield
2.90%
Growth
Revenue change (TTM)
13.17%
Earnings per share change (TTM)
19.00%
3-year revenue growth (CAGR)
9.58%
10-year revenue growth (CAGR)
9.76%
3-year earnings per share growth (CAGR)
71.40%
10-year earnings per share growth (CAGR)
6.11%
What the Analysts think about Kamada
Analyst ratings (Buy, Hold, Sell) for Kamada stock.
Kamada Financial Performance
Revenues and expenses
Kamada Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.